178 related articles for article (PubMed ID: 10233880)
1. The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply.
Loo M; Beguin Y
Blood; 1999 May; 93(10):3286-93. PubMed ID: 10233880
[TBL] [Abstract][Full Text] [Related]
2. Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia.
Piron M; Loo M; Gothot A; Tassin F; Fillet G; Beguin Y
Blood; 2001 Jan; 97(2):442-8. PubMed ID: 11154221
[TBL] [Abstract][Full Text] [Related]
3. The effect of high doses of recombinant human erythropoietin on megakaryocytopoiesis and platelet production in splenectomized mice.
Tsukada J; Misago M; Kikuchi M; Sato T; Ogawa R; Oda S; Chiba S; Eto S
Br J Haematol; 1990 Oct; 76(2):260-8. PubMed ID: 2094328
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin and platelet production.
Beguin Y
Haematologica; 1999 Jun; 84(6):541-7. PubMed ID: 10366799
[TBL] [Abstract][Full Text] [Related]
5. Transient effect of erythropoietin on thrombocytopoiesis in vivo in mice.
Shikama Y; Ishibashi T; Kimura H; Kawaguchi M; Uchida T; Maruyama Y
Exp Hematol; 1992 Feb; 20(2):216-22. PubMed ID: 1544390
[TBL] [Abstract][Full Text] [Related]
6. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
[TBL] [Abstract][Full Text] [Related]
7. Large, chronic doses of erythropoietin cause thrombocytopenia in mice.
McDonald TP; Clift RE; Cottrell MB
Blood; 1992 Jul; 80(2):352-8. PubMed ID: 1627797
[TBL] [Abstract][Full Text] [Related]
8. Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.
Ahluwalia N; Skikne BS; Savin V; Chonko A
Am J Kidney Dis; 1997 Oct; 30(4):532-41. PubMed ID: 9328369
[TBL] [Abstract][Full Text] [Related]
9. Effects of short-term administration of recombinant human erythropoietin on rat megakaryopoiesis.
Yonemura Y; Kawakita M; Fujimoto K; Sakaguchi M; Kusuyama T; Hirose J; Kato K; Takatsuki K
Int J Cell Cloning; 1992 Jan; 10(1):18-27. PubMed ID: 1552221
[TBL] [Abstract][Full Text] [Related]
10. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients.
Chuang CL; Liu RS; Wei YH; Huang TP; Tarng DC
Nephrol Dial Transplant; 2003 Feb; 18(2):370-7. PubMed ID: 12543894
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload.
Tarng DC; Huang TP; Chen TW; Yang WC
Kidney Int Suppl; 1999 Mar; 69():S107-18. PubMed ID: 10084294
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation.
Ayash LJ; Elias A; Hunt M; Demetri G; Wheeler C; Tepler I; Schwartz G; Mazanet R; Reich E; McCauley M
Br J Haematol; 1994 May; 87(1):153-61. PubMed ID: 7947240
[TBL] [Abstract][Full Text] [Related]
13. Use of Aspirin in normalization of recombinant human erythropoietin-mediated hyper-reactivity of platelets in rats.
Soni HM; Vekaria AM; Rath AC; Belemkar S; Jain MR
Indian J Pharmacol; 2014; 46(3):328-33. PubMed ID: 24987182
[TBL] [Abstract][Full Text] [Related]
14. Perioperative recombinant human erythropoietin.
Levine EA; Gould SA; Rosen AL; Sehgal LR; Egrie JC; Sehgal HL; Levine HD; Moss GS
Surgery; 1989 Aug; 106(2):432-7; discussion 437-8. PubMed ID: 2763040
[TBL] [Abstract][Full Text] [Related]
15. Effect of recombinant human erythropoietin on platelets in patients with anemia of renal failure: correlation of platelet count with erythropoietic activity and iron parameters.
Beguin Y; Loo M; R'Zik S; Sautois B; Lejeune F; Rorive G; Fillet G
Eur J Haematol; 1994 Nov; 53(5):265-70. PubMed ID: 7813706
[TBL] [Abstract][Full Text] [Related]
16. Effect of purified recombinant human erythropoietin on anemia in rats with experimental renal failure induced by five-sixth nephrectomy.
Kawamura A; Higuchi M; Imai N; Kawaguchi T; Ogura Y
Biotherapy; 1990; 2(1):77-85. PubMed ID: 2400629
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of erythropoiesis in haemodialysis patients demonstrates gradual expansion of erythroblasts during constant treatment with recombinant human erythropoietin.
Beguin Y; Loo M; R'Zik S; Sautois B; Lejeune F; Rorive G; Fillet G
Br J Haematol; 1995 Jan; 89(1):17-23. PubMed ID: 7833259
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic analysis of recombinant human erythropoietin effect on reticulocyte production rate and age distribution in healthy subjects.
Pérez-Ruixo JJ; Krzyzanski W; Hing J
Clin Pharmacokinet; 2008; 47(6):399-415. PubMed ID: 18479174
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human erythropoietin in the treatment of anemia of prematurity.
Chen JY; Wu TS; Chanlai SP
Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
[TBL] [Abstract][Full Text] [Related]
20. Is erythropoietin a survival factor for red blood cells?
Polenakovic M; Sikole A
J Am Soc Nephrol; 1996 Aug; 7(8):1178-82. PubMed ID: 8866410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
